USA Today reporter Liz Szabo breaks news for a living. So she had to squeeze her investigation of Dr. Stanley Burzynski and the patients who died under his care into the few hours or minutes between breaking daily news.
I wouldn’t blame you if you thought the only thing that happened in the health sphere this year was the implosion of Healthcare.gov. There was some excellent reporting on the problems with the Affordable Care Act, but here are some stories you might have missed.
With days remaining until new abortion regulations take effect in Texas, attorneys for abortion providers and the state of Texas presented their final arguments Wednesday on whether those restrictions meet constitutional muster.
Some years ago, I began hearing from my sources that I should investigate the generic drug industry. A generic drug boom was underway and it had led to a gold-rush mentality, they said. There seemed no good way into this nebulous topic, and no way to assess the actual quality of U.S. generic drugs.
After hours of emotional debate, the Texas Senate late on Tuesday evening approved omnibus legislation to tighten abortion restrictions.
When an insurance company decides to deny coverage for a particular drug, it is easy for the pharmaceutical company to suddenly become David fighting Goliath.
In exposing the bullying and deceit of of the biotech industry, Jeffrey Smith’s mesmerizing film shines a bright light of hope that we can reclaim our health and our food systems. Watch it and be galvanized, inspired, and engaged. Then tell everyone you know.
At the center of one of the great medical controversies of our time, the mishmash around pain medication and addiction to prescription drugs has caused alarm in law enforcement and the public. But the realities of patients who have chronic pain problems, chronic addiction problems, or both, are not
The Chinese call it the hundred day cough. In Spanish it is tosferina or “Bark of the Dog.” Pertussis, a.k.a. whooping cough, is a disease that many thought to be a thing of the past, but has been making a comeback for several decades now. In some cases, it has been deadly.
A new strategy to cripple Obamacare, a legal loss for contraception critics, EPA to review fire retardant toxicity and more from our Daily Briefing.
